Related Experiment Videos
New chemotherapy agents in veterinary medicine
Antony S Moore1, Barbara E Kitchell
1Section of Oncology and Harrington Oncology Program, Tufts University School of Veterinary Medicine, 200 Westboro Road, North Grafton, MA 01536, USA. antony.moore@tufts.edu
Summary
Veterinary oncology is using older and newer anticancer drugs like lomustine, streptozocin, ifosfamide, and gemcitabine. Consult a veterinary oncologist for current treatment guidelines due to limited published data.
Area of Science:
- Veterinary Medicine
- Oncology
- Pharmacology
Background:
- Recent advancements in veterinary oncology have enabled the use of drugs previously considered too toxic for animal patients.
- Traditional and novel anticancer agents are increasingly being evaluated for efficacy in veterinary medicine.
Purpose of the Study:
- To summarize the veterinary experience with specific alkylating agents: lomustine, streptozocin, ifosfamide, and gemcitabine.
- To provide an overview of established and emerging chemotherapeutic options in veterinary oncology.
Main Methods:
- Review of published literature on the veterinary use of lomustine, streptozocin, ifosfamide, and gemcitabine.
- Synthesis of available data on efficacy, toxicity, and clinical application of these agents in animals.
Main Results:
- The article discusses the veterinary application of older agents (lomustine, streptozocin) and newer agents (ifosfamide, gemcitabine).
- Published literature on the use of these specific anticancer drugs in veterinary oncology is limited.
Conclusions:
- Veterinary oncologists should consult current literature and specialist advice when considering these chemotherapeutic agents.
- Further research and clinical trials are needed to establish definitive guidelines for these anticancer drugs in veterinary practice.